A growing number of patients are launching compensation claims against manufacturers of the heartburn medication Zantac. Complaints against the drug center around potential links to various forms of cancer, leading to a surge of claims. The US government has also phased out the sale of Zantac, further fueling concerns about its safety. Attorneys p